Anushka Bhaskar
Datos Biográficos
| ID | 6070872 |
|---|---|
| NOMBRE | Anushka Bhaskar |
| NOMBRES | Anushka |
| APELLIDO | Bhaskar |
| FIRMA | BHASKAR A |
| AFILIACIONES | Glasgow Centre for Population Health |
| ORCID | 0000-0002-6018-9058 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 4 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 4 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2023 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2024 |
| ÍNDICE H | 0 |
Use, Spending, and Prices of Adalimumab Following Biosimilar Competition
This cross-sectional study examines the use, spending, and prices of adalimumab biosimilars in the first year of market competition in the US
Excess Fatal Overdoses in the United States During the Covid-19 Pandemic by Geography and Substance Type
Objectives. To assess heterogeneity in pandemic-period excess fatal overdoses in the United States, by location (state, county) and substance type. Methods. We used seasonal autoregressive integrated moving average (SARIMA) models to estimate counterfactual death counts in the scenario that no pandemic had occurred. Such estimates were subtracted from actual death counts to assess the magnitude of pandemic-period excess mortality between March 20…
Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines
The Covid‐19 pandemic highlighted the need to examine public trust in the U.S. Food and Drug Administration (FDA) vaccine approval process and the role of political influence in the FDA's decisions. Ensuring that the FDA is itself trustworthy is important for justifying public trust in its actions, like vaccine approvals, thereby promoting public health. We propose five conditions of trustworthiness that the FDA should meet when it reviews vaccin…
What Should Be Clinicians’ Roles in Regulatory Assessment of Prospective Interventions’ Risks of Exacerbating Inequity
When there is an evidence base that could be used credibly to justify expedited US Food and Drug Administration review, emergency use authorization, or approval, interventions-in-development must be evaluated in terms of their possible downstream influence on public trust and confidence in regulatory processes during a national public health crisis. When regulatory decisions express overconfidence about a prospective intervention's success, there…
Sin obras prominentes en esta página.
Securing the Trustworthiness of the FDA to Build Public Trust in Vaccines
The Covid‐19 pandemic highlighted the need to examine public trust in the U.S. Food and Drug Administration (FDA) vaccine approval process and the role of political influence in the FDA's decisions. Ensuring that the FDA is itself trustworthy is important for justifying public trust in its actions, like vaccine approvals, thereby promoting public health. We propose five conditions of trustworthiness that the FDA should meet when it reviews vaccin…
What Should Be Clinicians’ Roles in Regulatory Assessment of Prospective Interventions’ Risks of Exacerbating Inequity
When there is an evidence base that could be used credibly to justify expedited US Food and Drug Administration review, emergency use authorization, or approval, interventions-in-development must be evaluated in terms of their possible downstream influence on public trust and confidence in regulatory processes during a national public health crisis. When regulatory decisions express overconfidence about a prospective intervention's success, there…
Use, Spending, and Prices of Adalimumab Following Biosimilar Competition
This cross-sectional study examines the use, spending, and prices of adalimumab biosimilars in the first year of market competition in the US
Excess Fatal Overdoses in the United States During the Covid-19 Pandemic by Geography and Substance Type
Objectives. To assess heterogeneity in pandemic-period excess fatal overdoses in the United States, by location (state, county) and substance type. Methods. We used seasonal autoregressive integrated moving average (SARIMA) models to estimate counterfactual death counts in the scenario that no pandemic had occurred. Such estimates were subtracted from actual death counts to assess the magnitude of pandemic-period excess mortality between March 20…
Medicine (4 obras) · Public health (3 obras) · Business (2 obras) · Economics (2 obras) · Health Systems, Economic Evaluations, Quality of Life (2 obras) · Actuarial science (1 obras) · Adalimumab (1 obras) · Agency (philosophy) (1 obras) · Biosimilar (1 obras) · Biosimilars and Bioanalytical Methods (1 obras)